Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to KIDNEY CANCER/RCC

The New England Journal of Medicine

Adjuvant Pembrolizumab after Nephrectomy in Renal Cell Carcinoma

Nephrology February 20th 2024

Dana-Farber Cancer Institute

Immunotherapy Post-Surgery Improves Overall Survival For Kidney Cancer

Oncology, Medical February 12th 2024

OBR Oncology

A Tale of Two ICIs: Adjuvant Pembro Ups Survival in RCC, Nivo Doesn’t

Oncology, Medical February 5th 2024

Dana-Farber Cancer Institute

FDA Approves Kidney Cancer Therapy After Dana-Farber-Led Research Shows Improved Outcomes For Patients with Advanced Disease

Nephrology January 8th 2024

Fox Chase Cancer Center

Fox Chase Cancer Center Study Challenges Assumptions About Cystic Renal Masses

Oncology, Medical November 6th 2023

Cancer Therapy Advisor

In Search of Real-world Data on RCC

Oncology, Medical October 17th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form